Man Group’s Cidara Therapeutics CDTX Stock Holding History

Man Group’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-116,713	Closed	-$25.8M	–	2412
2025 Q4	$25.8M	Buy	+116,713	New	+$18.9M	0.04%	409

Man Group's CDTX Position: Q1 2026 in Review

Man Group sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 116,713 shares — an estimated $25.8M sold.

Man Group first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $25.8M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Man Group reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Man Group sold 116,713 Cidara Therapeutics shares in Q1 2026, an estimated $25.8M.
Man Group first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Man Group's Cidara Therapeutics position peaked at $25.8M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.